EFFECT OF DUAL GLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE/GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ON WEIGHT LOSS IN SUBJECTS WITH OBESITY